BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shen S, Jiang L, Xiao GQ, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Xu MQ, Wei YG. Prophylaxis against hepatitis B virus recurrence after liver transplantation: A registry study. World J Gastroenterol 2015; 21(2): 584-592 [PMID: 25593480 DOI: 10.3748/wjg.v21.i2.584]
URL: https://www.wjgnet.com/1007-9327/full/v21/i2/584.htm
Number Citing Articles
1
Takashi Onoe, Hiroyuki Tahara, Yuka Tanaka, Hideki Ohdan. Prophylactic managements of hepatitis B viral infection in liver transplantationWorld Journal of Gastroenterology 2016; 22(1): 165-175 doi: 10.3748/wjg.v22.i1.165
2
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan, Daniel Shouval. Plotkin's Vaccines2023; : 389 doi: 10.1016/B978-0-323-79058-1.00027-X
3
Sammy Saab, Ping-yu Chen, Clara E. Saab, Myron J. Tong. The Management of Hepatitis B in Liver Transplant RecipientsClinics in Liver Disease 2016; 20(4): 721 doi: 10.1016/j.cld.2016.06.004
4
Mohamed A Abd El Aziz, Rodolfo Sacco, Antonio Facciorusso. Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature reviewAntiviral Chemistry and Chemotherapy 2020; 28: 204020662092133 doi: 10.1177/2040206620921331
5
Li-Ping Sheng, Jun-Chang Zhang, Zhi-Qiang Zhong, Xue-Han Sheng, Jing Ren, Gui-Qiang Wang. High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysisHepatology International 2023; 17(5): 1113 doi: 10.1007/s12072-022-10466-w
6
Myra Nasir, George Y. Wu. Prevention of HBV Recurrence after Liver Transplant: A ReviewJournal of Clinical and Translational Hepatology 2020; 8(2): 150 doi: 10.14218/JCTH.2020.00003
7
Ming Lei, Lu-Nan Yan, Jia-Yin Yang, Tian-Fu Wen, Bo Li, Wen-Tao Wang, Hong Wu, Ming-Qing Xu, Zhe-Yu Chen, Yong-Gang Wei. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in ChinaWorld Journal of Gastroenterology 2018; 24(48): 5525-5536 doi: 10.3748/wjg.v24.i48.5525
8
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis BWorld Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
9
Seong-Hwan Chang. Prevention of HBV Recurrence After Liver Transplant: Long-Term ResultsTransplantation Proceedings 2021; 53(5): 1707 doi: 10.1016/j.transproceed.2021.04.006
10
Ji-Na Zheng, Tian-Tian Zou, Hai Zou, Gui-Qi Zhu, Lu-Yi Ruan, Zhang Cheng, Sven Van Poucke, Ming-Hua Zheng. Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysisExpert Review of Anti-infective Therapy 2016; 14(10): 979 doi: 10.1080/14787210.2016.1220831
11
Samar K. Darweesh, Amal A. Gad, Kafya Akroof, Zainab A. ElLatif. Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safetyEuropean Journal of Gastroenterology & Hepatology 2019; 31(5): 607 doi: 10.1097/MEG.0000000000001377
12
Afroditi Orfanidou, George V. Papatheodoridis, Evangelos Cholongitas. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current conceptsLiver International 2021; 41(7): 1448 doi: 10.1111/liv.14860
13
Nadeem Anwar, Kenneth E. Sherman. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical?Journal of Viral Hepatitis 2018; 25(10): 1110 doi: 10.1111/jvh.12962
14
Xie Man, Rao Wei. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantationEuropean Journal of Inflammation 2022; 20: 1721727X2211392 doi: 10.1177/1721727X221139254
15
Ming Shu Li, Zhou Hua Hou, Guo Zhu Yao, De Ming Tan. The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV‐related diseases in the era of potent nucleos(t)ide analogues: A meta‐analysisJournal of Digestive Diseases 2021; 22(2): 91 doi: 10.1111/1751-2980.12959
16
Pierre Van Damme, John W. Ward, Daniel Shouval, Alessandro Zanetti. Plotkin's Vaccines2018; : 342 doi: 10.1016/B978-0-323-35761-6.00025-0